Update on the optimal use of voriconazole for invasive fungal infections

Asma Lat, George R. Thompson

Research output: Contribution to journalReview articlepeer-review

65 Scopus citations


Voriconazole is an extended-spectrum triazole with excellent bioavailability that has now become the treatment of choice for aspergillosis. It has a unique side effect profile compared with other azoles, as well as a number of clinically important drug-drug interactions. These factors, along with a correlation between increased serum levels and improved outcomes, have prompted an interest in therapeutic drug monitoring of this agent. The pharmacology and clinical outcomes data of voriconazole are presented in this review.

Original languageEnglish (US)
Pages (from-to)43-53
Number of pages11
JournalInfection and Drug Resistance
Issue number1
StatePublished - 2011
Externally publishedYes


  • Aspergillosis
  • Candidiasis
  • Therapeutic drug monitoring
  • Voriconazole

ASJC Scopus subject areas

  • Pharmacology
  • Infectious Diseases
  • Pharmacology (medical)


Dive into the research topics of 'Update on the optimal use of voriconazole for invasive fungal infections'. Together they form a unique fingerprint.

Cite this